“…Although there is no record as to why the time between both interventions is short, current guidelines specify that alteplase administration should not delay MT. 8 It was previously suggested that in centers where the “drip and ship” protocol is applied, MT could be delayed; 26 , 27 however, the difference between the median door-to-groin-puncture time in both groups is nor clinically or statistically significant, being mostly less than 5 min, excepting the DIRECT SAFE trial, in which there is a 14-min delay in the BT group. It is likely that in a different scenario from the trial setting, the time between both interventions would be longer, which may lead to variations in the outcomes.…”